검색어 : 통합검색[Opera Australia]
총 165건 중 165건 출력
, 17/17 페이지
-
161
- OPERA-01: A randomized, open-label, phase 3 study of palazestrant (OP-1250) vs standard-of-care for patients with ER+, HER2- advanced or metastatic breast cancer after endocrine therapy and CDK4/6 inhibitors.
- Sohn, Joohyuk; Pistilli, Barbara; Bellet, Meritxell; Del Mastro, Lucia; McArthur, Heather L.; Meisel, Jane Lowe; Schmid, Peter; Wei, Rachel; Chan, Arlene; de Kermadec, Elisabeth; Division of Medical Oncology, Yonsei Cancer Center, Seoul, South Korea; Gustave Roussy, Department of Medical Oncology, Villejuif, France; Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology, Barcelona, Spain; Clinical Oncology Department, IRCCS Ospedale Policlinico San Martino Genoa, Genova, Italy; University of Texas Southwestern Medical Center, Dallas, TX; Winship Canter Institute of Emory University, Atlanta, GA; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom; Olema Oncology, San Francisco, CA; Breast Cancer Research Centre - WA & Curtin University, Nedlands, Australia; Olema Oncology, Cambridge, MA; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.42, 2024, pp.TPS22-TPS22)
-
162
- Circulating cardiac biomarkers and postoperative atrial fibrillation in the OPERA trial
- Masson, Serge; Wu, Jason H. Y.; Simon, Caterina; Barlera, Simona; Marchioli, Roberto; Mariani, Javier; Macchia, Alejandro; Lombardi, Federico; Vago, Tarcisio; Aleksova, Aneta; Dreas, Lorella; Favaloro, Roberto R.; Hershson, Alejandro R.; Puskas, John D.; Dozza, Luca; Silletta, Maria G.; Tognoni, Gianni; Mozaffarian, Dariush; Latini, Roberto; ; (European journal of clinical investigation, v.45, 2015, pp.170-178)
-
163
- Abstract 12364: Circulating Cardiac and Inflammatory Biomarkers to Predict Post-Operative Atrial Fibrillation in the OPERA Trial
- Masson, Serge; Wu, Jason H; Barlera, Simona; Bani, Laura; Marchioli, Roberto; Macchia, Alejandro; Vago, Tarcisio; Puskas, John D; Favaloro, Roberto René ; Hershson, Alejandro Rubé n; Sinatra, Riccardo; Melina, Giovanni; Nicolosi, Liliana; Dreas, Lorella; VanderWoude, John; Tognoni, Gianni; Mozaffarian, Darisuh; Latini, Roberto; Cardiovascular Rsch, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy; The George Institute for Global Health, Sydney Med Sch, Univ of Sydney, Sydney, Australia; Cardiovascular Rsch, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy; S.C. Analisi Chimico Cliniche, Azienda Ospedaliera di Desio e Vimercate, Desio, Italy; Hematology-Oncology Therapeutic Delivery Unit, Quintiles, Milano, Italy; GESICA Foundation, GESICA Foundation, Buenos Aires, Argentina; Laboratory of Endocrinology, Ospedale Luigi Sacco, Milano, Italy; Div of Cardiothoracic Surgery,, Emory Univ Hosp Midtown, Atlanta, GA; Fundacion Favaloro, Fundacion Favaloro, Buenos Aires, Argentina; Fundacion Favaloro, Fundacion Favaloro, Buenos Aires, Argentina; U.O.C. Cardiochirurgia, Ospedale S. Andrea - La Sapienza, Rome, Italy; U.O.C. Cardiochirurgia, Ospedale S. Andrea - La Sapienza, Rome, Italy; Dept of Cardiology, Hosp Españ ol, Buenos Aires, Argentina; Cardiovascula; (Circulation, v.130, 2014, )
-
164
- Oxidative Stress Biomarkers and Incidence of Postoperative Atrial Fibrillation in the Omega-3 Fatty Acids for Prevention of Postoperative Atrial Fibrillation (OPERA) Trial
- Wu, Jason H Y; Marchioli, Roberto; Silletta, Maria G; Masson, Serge; Sellke, Frank W; Libby, Peter; Milne, Ginger L; Brown, Nancy J; Lombardi, Federico; Damiano, Ralph J; Marsala, Joann; Rinaldi, Mauro; Domenech, Alberto; Simon, Caterina; Tavazzi, Luigi; Mozaffarian, Dariush; George Institute for Global Health, Sydney Medical School, The University of Sydney New South Wales, Australia (J.H.Y.W.); Hematology-Oncology Therapeutic Delivery Unit, Quintiles Milan, Italy (R.M.); Laboratory of Clinical Epidemiology of Cardiovascular Disease, Fondazione Mario Negri Sud Santa Maria Imbaro, Italy (M.G.S.); Department of Cardiovascular Research, IRCCS— Istituto di Ricerche Farmacologiche “Mario Negri” Milan, Italy (S.M.); Division of Cardiothoracic Surgery, Cardiovascular Research Center, Brown University Warren Alpert School of Medicine Providence, RI (F.W.S.); Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School Boston, MA (P.L.); Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University School of Medicine Nashville, TN (G.L.M.); Department of Medicine, Vanderbilt University Medical Center Nashville, TN (N.J.B.); U.O.C. di Malattie Cardiovascolari, Fondazione IRCC; (Journal of the American Heart Association : cardiovascular and cerebrovascular disease, v.4, 2015, pp.e001886)
-
165
- Design of the omapatrilat in persons with enhanced risk of atherosclerotic events (OPERA) trial
- Kostis, John B; Cobbe, Stuart; Johnston, Colin; Ford, Ian; Murphy, Michael; Weber, Michael A; Black, Henry R; Plouin, Pierre Francois; Levy, Daniel; Mancia, Guiseppe; Larochelle, Pierre; Kolloch, Rainer E; Alderman, Michael; Ruilope, Luis Miguel; Dahlö f, Bjö rn; Flack, John M; Wolf, Robert; ; (American journal of hypertension : journal of the American Society of Hypertension, v.15, 2002, pp.193-198)
QUICK MENU
